Objective rhinomanometric clinical testing of an antihistamine (clemastine) combined with adrenergic substance (phenylpropanolamine).
D000284:Administration, Oral; D002849:Chromatography, Gas; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006634:Histamine H1 Antagonists / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D008365:Manometry; D010665:Phenylpropanolamine / Q000008:administration & dosage* / Q000627:therapeutic use; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D010919:Placebos; D010665:Phenylpropanolamine